A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

February 13, 2023

Study Completion Date

March 23, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

NNC0480-0389

A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

DRUG

Semaglutide

A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

DRUG

Placebo (NNC080-0389)

A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

DRUG

Placebo (semaglutide)

A weekly dose of placebo (semaglutide). The study will last for about 41weeks.

Trial Locations (83)

1036

Clinexpert Egészségügyi Szolgáltató és Kereskedelmi Kft., Budapest

1106

Bajcsy-Zsilinszky Kórház, Budapest

1132

MED-TIMA Kft., Budapest

1134

MH Egészségügyi Központ, Budapest

1431

UMHAT Aleksandrovska, Sofia

1632

Medical centre - Doverie AD, Sofia

1797

UMHAT Sofiamed, Sofia

2650

Hvidovre Hospital Endokrinologisk forsknings afsnit 159, Hvidovre

2850

IPMC - Dr. Elizabeta Dimitrova, Petrich

2900

Center for Klinisk Metabolisk Forskning, Hellerup

3320

"Medical centre Zdrave 1 OOD", Kozloduy

4032

Debreceni Egyetem Belgyógyászati Klinika, Debrecen

4043

Debreceni Egyetem Klinikai Központ Belgyógyászati Klinika D épület, Debrecen

6000

"Prevencia-2000-MCOC", Stara Zagora

7400

Kaposi Mór Oktató Kórház, Kaposvár

7623

PTE-AOK II. Belgyogyaszati Klinika es Nephrologiai Centrum, Pécs

8200

Aarhus Universitetshospital Diabetes og Hormonsygdomme, Aarhus N

9700

Vas Vármegyei Markusovszky Egyetemi Oktatókórház, Szombathely

11000

Endocrinology, Diabetes and Metabolism Diseases Clinic, Belgrade

11527

"Laiko General Hospital of Athens", Athens

11528

Alexandra General Hospital, Therapeutic Clinic, Athens

12203

AMC Community Endocrinology, Albany

12462

University Hospital of Athens ATTIKON, Athens

15125

Iatriko Athinon (Athens Medical Canter), Athens

17562

Iatriko Athinon 'Palaiou Falirou', Athens

27408

PharmQuest Life Sciences LLC, Greensboro

27514

University of North Carolina, Chapel Hill

27834

Physicians East Endocrinology, Greenville

28625

Piedmont Healthcare/Research, Statesville

32127

Progressive Medical Research, Port Orange

32204

Northeast Research Institute, Jacksonville

33027

South Broward Research LLC, Miramar

33175

Reyes Clinical Research, Inc, Miami

34000

Clinical Centre Kragujevac, Internal Diseases Clinic, Endocrinology department, Kragujevac

Clinical Centre Kragujevac, Internal Diseases Clinic, Endocr, Kragujevac

34243

Headlands Research - Sarasota, Sarasota

40503

The Research Group of Lexington LLC, Lexington

43537

Advanced Med Res Maumee, Maumee

48098

Arcturus HC PLC Troy Med Res, Troy

50265

Iowa Diabetes & Endo Res Ctr, West Des Moines

54645

EUROMEDICA Gen Clinic The/ki, Endocrin,Metabolism,Diabetes, Thessaloniki

57001

"Thermi Private Hosital", Thessaloniki

59701

Mercury Str Med Grp, PLLC, Butte

60607

Cedar-Crosse Research Center, Chicago

74137

Essential Medical Research LLC, Tulsa

75230

Velocity Clinical Res-Dallas, Dallas

78209

Quality Research Inc, San Antonio

78230

VIP Trials_San Antonio, San Antonio

78231

Consano Clinical Research, LLC, Shavano Park

83646

Solaris Clinical Research, Meridian

90017

Velocity Clin Res Los Angeles, Los Angeles

90717

Torrance Clin Res Inst, Inc., Lomita

91304

San Fernando Valley Hlth Inst, LLC, Canoga Park

91325

Valley Clinical Trials, Inc., Northridge

91911

Velocity Clin Res-Chula Vista, Chula Vista

91942

Velocity Clinical Research San Diego, La Mesa

92025

Headlands Research California, LLC, Escondido

92103

Artemis Institute for Clin Res, San Diego

92503

Artemis Insitute for Clin Res, Riverside

92835

Providence Medical Foundation, Fullerton

93534

First Valley Med Grp Lancaster, Lancaster

194356

Medinet LLC, Saint Petersburg

440026

Penza Regional Clinical Hospital named after N.N. Burdenko, Penza

625023

Tumen State Medical University, Tyumen

630005

LLC RC Medical, Novosibirsk

02115-5804

Brigham & Women's Hospital, Boston

75390-9302

UT Southwestern Med Cntr, Dallas

311-0113

Naka Kinen Clinic_Internal medicine, Ibaraki

861-8039

Yoshimura clinic, Kumamoto

553-0003

Kansai Electric Power Hospital_Center for Diabetes, Osaka

103-0028

Tokyo Center Clinic, Tokyo

160-0008

ToCROM Clinic, Tokyo

169-0072

Higashi-shinjuku clinic, Tokyo

15-879

NZOZ Vita-Diabetica Malgorzata Buraczyk, Bialystok

31-501

Krakowskie Centrum Medyczne Sp. z o.o., Krakow

90-338

Centrum Terapii Współczesnej J.M. Jasnorzewska S.K.A., Lodz

91-363

FutureMeds Sp. z o.o. Lodz, Lodz

87-100

Osrodek Badan Klinicznych Clinsante, Torun

00-215

Centrum Medyczne AMED Warszawa, Warsaw

02-507

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji, Warsaw

50-088

FutureMeds Sp. z o.o., Wroclaw

41-800

SPSK nr 1 im. prof. Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach, ul. 3-go Maja 13/15 41-800 Zabrze, Zabrze

28-200

Velocity Nova Sp. z o.o., Staszów

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05144984 - A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes | Biotech Hunter | Biotech Hunter